Skip to content

Neil Kumar, Chief Executive Officer at BridgeBio Pharma, sold BBIO on Aug 18, 2026

Data as of Oct 16

▼ SELL$154K1,900 shares at $81.15Neil Kumar Chief Executive OfficerBBIO BridgeBio Pharma, Inc.
Watch BBIO
Traded
Aug 18, 2026
Disclosed
Aug 20, 2026
Filed
2 days after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Neil Kumar, Chief Executive Officer at BridgeBio Pharma, sold BBIO on Aug 18, 2026TRADEDDISCLOSED
BBIOSimilar stocks (XLV — its sector index fund), rebased to BBIO's price on the disclosure day
BBIO since disclosure
−20.0%
after the sale
Similar stocks (XLV) since disclosure
+2.5%
XLV — its sector index fund

Change in closing price from Aug 20, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLNeil Kumar Chief Executive OfficerBBIO BridgeBio Pharma, Inc.$8.6Kdisclosed Aug 20 · filed 1 day after the trade
  2. ▼ SELLNeil Kumar Chief Executive OfficerBBIO BridgeBio Pharma, Inc.$152Kdisclosed Aug 20 · filed 1 day after the trade
  3. ▼ SELLNeil Kumar Chief Executive OfficerBBIO BridgeBio Pharma, Inc.$679Kdisclosed Aug 20 · filed 1 day after the trade
  4. ▼ SELLNeil Kumar Chief Executive OfficerBBIO BridgeBio Pharma, Inc.$1.4Mdisclosed Aug 20 · filed 2 days after the trade
  5. ▼ SELLNeil Kumar Chief Executive OfficerBBIO BridgeBio Pharma, Inc.$100Kdisclosed Aug 20 · filed 2 days after the trade
  6. ▼ SELLNeil Kumar Chief Executive OfficerBBIO BridgeBio Pharma, Inc.$1.2Mdisclosed Aug 20 · filed 2 days after the trade

See every trade on BBIO →